Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NR. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104529803B reveals a novel amide synthesis route using triethylenediamine. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Patent CN101857547A reveals a mild PTC method for 2-nitro-1-aryl alcohol synthesis, offering high purity, scalable production, and significant cost reduction in API manufacturing.
Patent CN105399744B reveals optimized Omarigliptin synthesis. High yield and purity benefit supply chain stability and cost reduction significantly.
Patent CN102285896B details a novel chloramphenicol synthesis using benzaldehyde, offering high purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN100564357C reveals a palladium-free route for azetidinone derivatives. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN102399163B reveals a high-yield 4-step route to Chloramphenicol using 4-chlorobenzaldehyde, eliminating resolution and reducing waste for reliable API intermediate supply.
Novel synthesis method for NR chloride using TMSOTf activation. Reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Patent CN106349130B reveals asymmetric Henry reaction for Florfenicol. Reduces waste and cost for veterinary antibiotic manufacturing supply chains.
Patent CN108864252B reveals a scalable liquid-phase synthesis for NRX-1074, offering high purity without preparative HPLC for reliable API intermediate supply.
Solve chiral purity challenges in halichondrin synthesis with 99.7% ee and 92% yield. Reduce impurity removal burden for Eribulin mesylate production. CDMO expertise for scalable manufacturing.